furosemide / Generic mfg.  >>  Phase 3
Welcome,         Profile    Billing    Logout  

4 Trials

Remove FilterRemove FilterRemove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
furosemide / Generic mfg.
NCT00151827: Olmesartan Medoxomil in Hypertension and Renal Impairment

Completed
3
393
Europe
Olmesartan medoxomil, Losartan, Furosemide oral tablets
Sankyo Pharma Gmbh
Essential Hypertension, Renal Impairment
07/05
07/05
NCT01210365: Safety and Efficacy of Furosemide 40mg + Amiloride Hydrochloride 10mg to Reduct Edema

Terminated
3
27
RoW
Diurisa®, Lasix ®
Eurofarma Laboratorios S.A.
Congestive Heart Failure
03/13
03/13
NCT02971891: A Phase 3 Study to Evaluate the Efficacy and Safety of CLS006 Versus Vehicle in Subjects 2 Years of Age or Older With Cutaneous Common Warts

Completed
3
484
US
CLS006 (Furosemide) Topical Gel, Vehicle Topical Gel
Maruho Co., Ltd.
Cutaneous Common Warts
04/18
07/18
NCT02329834: Crossover Study to Compare the Pharmacokinetics and Bioavailability of a Novel Furosemide Regimen Administered Subcutaneously vs. the Same Dose Administered Intravenously in Subjects With Chronic Heart Failure

Completed
2/3
23
US
Fursemide Injection Solution for subcutaneous administration (80 mg), Furosemide Injection, USP
scPharmaceuticals, Inc.
Heart Failure
10/15
10/15

Download Options